Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more cancer cells.
Chemoprotective drugs such as amifostine may protect normal cells from the side effects of
chemotherapy.
PURPOSE: Phase II trial to study the effectiveness of combining topotecan and cytarabine
given with amifostine in treating patients who have myelodysplastic syndrome.